Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2022 | 3 |
2023 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Neoadjuvant immunotherapy in early-stage triple negative breast cancer.
Ann Transl Med. 2023 Aug 30;11(10):338. doi: 10.21037/atm-23-1550. Epub 2023 Jun 27.
Ann Transl Med. 2023.
PMID: 37675326
Free PMC article.
No abstract available.
Is there a window of opportunity to optimize trastuzumab cardiac monitoring?
Rala de Paula BH, Costa METF, de Sousa CAM, Bines J.
Rala de Paula BH, et al.
World J Cardiol. 2022 Jul 26;14(7):403-410. doi: 10.4330/wjc.v14.i7.403.
World J Cardiol. 2022.
PMID: 36161060
Free PMC article.
Item in Clipboard
Clinical considerations for estrogen receptor-negative/progesterone receptor-positive/HER2-negative (ER-PR+HER2-) breast cancer.
Rala de Paula BH, Crocamo S, Bines J.
Rala de Paula BH, et al.
Transl Breast Cancer Res. 2022 Oct 28;4:8. doi: 10.21037/tbcr-22-41. eCollection 2023.
Transl Breast Cancer Res. 2022.
PMID: 38751458
Free PMC article.
No abstract available.
Item in Clipboard
Aiming for the Cure in ERBB2-Positive Metastatic Breast Cancer-Should We Go "All In"?
Rala de Paula BH, Crocamo S.
Rala de Paula BH, et al.
JAMA Oncol. 2022 Aug 1;8(8):1220-1221. doi: 10.1001/jamaoncol.2022.1919.
JAMA Oncol. 2022.
PMID: 35708670
No abstract available.
Item in Clipboard
Nuclear and Cytoplasmic hTERT, Tumor-Infiltrating Lymphocytes, and Telomere Elongation Leukocytes Are Independent Factors in the Response to Neoadjuvant Treatment in HER2-Enriched Breast Cancer.
Delmonico L, Bines J, Nascimento CMD, Fernandes PV, Barbosa IS, Ribeiro GB, de Paula BHR, Silvestre RT, Ornellas MHF, Alves G, Lage C.
Delmonico L, et al. Among authors: de paula bhr.
Curr Oncol. 2023 Apr 7;30(4):4094-4109. doi: 10.3390/curroncol30040311.
Curr Oncol. 2023.
PMID: 37185424
Free PMC article.
Item in Clipboard
Sociodemographic, Clinical, and Pathological Factors Influencing Outcomes in Locally Advanced Triple Negative Breast Cancer: A Brazilian Cohort.
da Silva JL, de Paula BHR, Small IA, Thuler LCS, de Melo AC.
da Silva JL, et al. Among authors: de paula bhr.
Breast Cancer (Auckl). 2020 Sep 25;14:1178223420962488. doi: 10.1177/1178223420962488. eCollection 2020.
Breast Cancer (Auckl). 2020.
PMID: 33029072
Free PMC article.
Item in Clipboard
Real-world assessment of the effect of impact of tumor size on pathological complete response rates in triple negative breast cancer after neoadjuvant chemotherapy.
de Paula BHR, Kumar S, Morosini FM, Calábria Cardoso DEM, de Sousa CAM, Crocamo S.
de Paula BHR, et al.
Chin Clin Oncol. 2020 Dec;9(6):78. doi: 10.21037/cco-20-111. Epub 2020 Nov 10.
Chin Clin Oncol. 2020.
PMID: 33183012
Free article.
Item in Clipboard
Cite
Cite